SEC Form 4 · accession 0001209191-15-087387
ACHILLION PHARMACEUTICALS INC · ACHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Apelian
Officer — Chief Medical Officer
Period of report
Dec 30, 2015
Accepted (ET)
Dec 30, 2015 · 4:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 30, 2015 | M | 10,000 | $3.02 | A | 10,000 | D | |
| Common Stock | Dec 30, 2015 | S | 10,000 | $10.50 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF1 | $3.02 | Dec 30, 2015 | M | 10,000 | D | — | Dec 17, 2023 | Common Stock | 10,000 | 290,000 | D |
Explanation of responses
- F1This option was granted on December 17, 2013 and vests over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three month-month period thereafter.
Remarks
The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-a trading plan adopted by Mr. Apelian on December 1, 2015.